BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 50 | -80.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 250 | -44.4% | 0.00% | – |
| Q4 2017 | $2,000 | -66.7% | 450 | -55.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 1,000 | -50.0% | 0.00% | – |
| Q3 2016 | $9,000 | +80.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |